BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/24/2025 7:30:27 AM | Browse: 2 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 113816
Country China
Category Gastroenterology & Hepatology
Manuscript Type Meta-Analysis
Article Title Efficacy of regorafenib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Zhang Cheng and Ai-Min Yue
Funding Agency and Grant Number
Corresponding Author Ai-Min Yue, MD, Department of Surgical Oncology, Xinxiang Central Hospital, The Fourth Clinical College of Xinxiang Medical University, No. 56 Jinsui Avenue, Xinxiang 453000, Henan Province, China. yueaimin2025@163.com
Key Words Regorafenib; Hepatocellular carcinoma; Second-line therapy; Overall survival; Meta-analysis
Core Tip This study presents a comprehensive synthesis of current evidence regarding regorafenib’s clinical performance as a second-line treatment in patients with advanced hepatocellular carcinoma. Utilizing data from nine eligible studies, our meta-analysis provides an updated assessment of survival outcomes and tumor response metrics. Notably, regorafenib demonstrated a statistically significant improvement in overall survival compared to control groups, while objective tumor response rates did not show superiority, particularly when compared to immunotherapies such as nivolumab. Our results highlight regorafenib’s survival benefit and its role within a competitive therapeutic landscape.
Citation Cheng Z, Yue AM. Efficacy of regorafenib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis. World J Gastrointest Oncol 2025; In press
Received
2025-09-04 03:28
Peer-Review Started
2025-09-04 03:28
To Make the First Decision
Return for Revision
2025-09-29 09:28
Revised
2025-10-12 04:19
Second Decision
2025-11-24 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-11-24 07:30
Articles in Press
2025-11-24 07:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com